Join
Live feed
·
INSIDERFilingvia Quantisnow
Terns Pharmaceuticals Inc. logo

Chief Financial Officer Gengos Andrew returned $3,643,750 worth of shares to the company (68,750 units at $53.00), closing all direct ownership in the company (SEC Form 4) (withholding obligation)

ByQuantisnow·Wall Street's wire, on your screen.
TERN· Terns Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TERN (Terns Pharmaceuticals Inc.) and more on Quantisnow.